Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Constantin Dasanu

Title(s)Clinical Professor (Voluntary), Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mosunetuzumab-associated fatal HHV-6 encephalitis in a patient with follicular lymphoma. J Oncol Pharm Pract. 2025 Oct; 31(7):1183-1187. Samperio VM, Hamoud M, Dasanu CA. PMID: 40625203.
      View in: PubMed   Mentions:
    2. Selecting optimal therapy for large granular lymphocytic (LGL) leukemia: current state and future prospects based on molecularly-defined characterization. Expert Opin Pharmacother. 2025 Aug; 26(11-12):1259-1261. Samperio VM, Ike I, Dasanu CA. PMID: 40530748.
      View in: PubMed   Mentions:
    3. Rothia aeria Causing Prosthetic Valve Endocarditis in an Immunocompetent Patient. Cureus. 2025 Jun; 17(6):e85286. Leker K, El-Khoury DT, Endo Z, Vu A, Mdluli X, Dasanu CA. PMID: 40612838; PMCID: PMC12225649.
      View in: PubMed   Mentions:
    4. Pseudocellulitis Due to Antineoplastic Therapy: A Case of Atypical Presentation and Recent Developments. Cureus. 2025 May; 17(5):e84688. Salmasi S, Gafarzadeh Z, Alchaikh Hassan R, Dasanu CA. PMID: 40546582; PMCID: PMC12182961.
      View in: PubMed   Mentions:
    5. Selecting optimal therapy for Langerhans cell histiocytosis: current state and future directions. Expert Opin Pharmacother. 2025 Jun; 26(9):1005-1008. Hamoud M, Alchaikh Hassan R, Dasanu CA. PMID: 40377406.
      View in: PubMed   Mentions:
    6. Selecting appropriate therapy for cutaneous T-cell lymphomas (CTCLs): recent advances and the unmet need. Expert Opin Pharmacother. 2025 Jun; 26(8):923-925. Poursadrolah S, Alchaikh Hassan R, Codreanu I, Dasanu CA. PMID: 40336318.
      View in: PubMed   Mentions:
    7. Complete color vision loss in a patient with metastatic melanoma of the skin treated with nivolumab-relatlimab. J Oncol Pharm Pract. 2025 Sep; 31(6):1014-1017. Alchaikh Hassan R, Vu A, Tsai H, Dasanu CA. PMID: 40356467.
      View in: PubMed   Mentions:
    8. Selecting optimal therapy in systemic mastocytosis: current state and future directions. Expert Opin Pharmacother. 2025 Jun; 26(8):915-917. Ike I, Samperio V, Dasanu CA. PMID: 40334058.
      View in: PubMed   Mentions:
    9. Selecting optimal therapy for advanced non-functional pancreatic neuroendocrine tumors: latest research and therapeutic advances. Expert Opin Pharmacother. 2025 Jun; 26(8):909-913. Alchaikh Hassan R, Patel A, Dasanu CA. PMID: 40316435.
      View in: PubMed   Mentions:
    10. Pulmonary Coccidioidomycosis Occurring in a Patient Treated With Acalabrutinib for Chronic Lymphocytic Leukemia. Cureus. 2025 Apr; 17(4):e83026. Gafarzadeh Z, Gaultier C, Salmasi S, Alchaikh Hassan R, Dasanu CA. PMID: 40421329; PMCID: PMC12104961.
      View in: PubMed   Mentions:
    11. Selecting optimal therapy for higher-risk myelodysplastic syndromes: present and future projections. Expert Opin Pharmacother. 2025 Mar; 26(4):345-347. Teymouri F, Dasanu CA. PMID: 39956939.
      View in: PubMed   Mentions:
    12. Neoadjuvant Cetuximab Leading to a Complete Pathologic Response in Locally Advanced Lip Squamous Cell Carcinoma. Cureus. 2024 Dec; 16(12):e75000. Alchaikh Hassan R, Gafarzadeh Z, Salmasi S, Hyams DM, Dasanu CA. PMID: 39749049; PMCID: PMC11693926.
      View in: PubMed   Mentions:
    13. Change in hair texture with the use of pomalidomide for multiple myeloma: From straight to curly phenotype. J Oncol Pharm Pract. 2025 Apr; 31(3):507-510. Zahid A, Dasanu CA. PMID: 39584738.
      View in: PubMed   Mentions:
    14. Temozolomide overcoming resistance to immune checkpoint inhibitors in relapsed/refractory metastatic melanoma? Insights from a single center series. J Oncol Pharm Pract. 2025 Mar; 31(2):321-324. Dasanu CA, Plaxe SC. PMID: 39584741.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Severe Relapsing Hailey-Hailey Disease Displaying a Durable Complete Response to Hydroxyurea. Acta Dermatovenerol Croat. 2024 Nov; 32(3):168-169. Dasanu CA. PMID: 40654217.
      View in: PubMed   Mentions:
    16. Erlotinib-induced Perioral Lesions Resembling Scleroderma. Acta Dermatovenerol Croat. 2024 Nov; 32(2):118-119. Dasanu CA, Alvarez-Argote J, Dasanu RG, Soliman A, Codreanu I. PMID: 39803739.
      View in: PubMed   Mentions:
    17. Selecting appropriate therapy for lower-risk myelodysplastic syndromes: current state and future prospects. Expert Opin Pharmacother. 2024 Oct; 25(15):1975-1977. Teymouri F, Dasanu CA. PMID: 39387446.
      View in: PubMed   Mentions:
    18. Recurrent, multisystem angioedema induced by 5-azacitidine. J Oncol Pharm Pract. 2025 Apr; 31(3):503-506. Alchaikh Hassan R, Salmasi S, Ghafarzadeh Z, Dasanu CA. PMID: 39363705.
      View in: PubMed   Mentions:
    19. Nearly complete hair re-pigmentation in an older patient treated with hydroxyurea for essential thrombocytosis. J Oncol Pharm Pract. 2025 Apr; 31(3):499-502. Salmasi S, Hassan RA, Gafarzadeh Z, Dasanu CA. PMID: 39311334.
      View in: PubMed   Mentions:
    20. Evaluation of infectious morbidity due to BTK inhibitors in indolent B-cell lymphomas: latest research findings and systematic analysis. Expert Opin Pharmacother. 2024 08; 25(11):1525-1540. Dasanu CA, Mann SK, Baidya M, Mdluli XP, Stapleton AE, Codreanu I. PMID: 39109526.
      View in: PubMed   Mentions:
    21. Sjogren's syndrome due to immune checkpoint inhibitors (ICIs): Insights from a single-institution series and systematic review of the literature. J Oncol Pharm Pract. 2025 Oct; 31(7):1029-1036. Soliman A, Hassan R, Codreanu I, Plaxe SC, Dasanu CA. PMID: 39113536.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Oral lichenoid drug eruption due to osimertinib for lung cancer. J Oncol Pharm Pract. 2024 Oct; 30(7):1278-1281. Alchaikh Hassan R, Soliman A, Dasanu CA. PMID: 39090853.
      View in: PubMed   Mentions:
    23. A case of palmar-plantar erythrodysesthesia in a lung cancer patient receiving atezolizumab maintenance. J Oncol Pharm Pract. 2024 Sep; 30(6):1122-1125. Teymouri F, Dasanu CA. PMID: 38813782.
      View in: PubMed   Mentions:
    24. Unusual encephalopathy with Wernicke-Korsakoff syndrome-like features due to adjuvant nivolumab for malignant melanoma. J Oncol Pharm Pract. 2024 Mar; 30(2):408-411. Malik S, White W, Dasanu CA. PMID: 37981786.
      View in: PubMed   Mentions:
    25. Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial. Nat Med. 2023 09; 29(9):2278-2285. VanderWalde A, Bellasea SL, Kendra KL, Khushalani NI, Campbell KM, Scumpia PO, Kuklinski LF, Collichio F, Sosman JA, Ikeguchi A, Victor AI, Truong TG, Chmielowski B, Portnoy DC, Chen Y, Margolin K, Bane C, Dasanu CA, Johnson DB, Eroglu Z, Chandra S, Medina E, Gonzalez CR, Baselga-Carretero I, Vega-Crespo A, Garcilazo IP, Sharon E, Hu-Lieskovan S, Patel SP, Grossmann KF, Moon J, Wu MC, Ribas A. PMID: 37592104; PMCID: PMC10708907.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    26. Immune checkpoint inhibitor-related adverse events: Real-world experience from a single veterans' affairs medical center. J Oncol Pharm Pract. 2024 Jun; 30(4):697-704. Benz S, Sherman KA, Dasanu CA, Alvarez-Argote J. PMID: 37350125.
      View in: PubMed   Mentions:
    27. Unusual stroke-like symptoms with oxaliplatin use. J Oncol Pharm Pract. 2023 Oct; 29(7):1766-1769. Soliman A, Habibi S, Dasanu CA. PMID: 37323007.
      View in: PubMed   Mentions:
    28. Immune checkpoint inhibition in advanced colorectal cancer with inherited and acquired microsatellite instability: Current state and future directions. J Oncol Pharm Pract. 2023 May 29; 10781552231178293. Dasanu CA, Alani M, Habibi S, Codreanu I. PMID: 37246506.
      View in: PubMed   Mentions:
    29. Acquired angioedema late in the course of nivolumab treatment. J Oncol Pharm Pract. 2023 Apr 17; 10781552231170555. Habibi S, Patel N, Plaxe SC, Dasanu CA. PMID: 37069828.
      View in: PubMed   Mentions:    Fields:    
    30. Widespread vitiligo and poliosis following ipilimumab-nivolumab combination therapy. J Oncol Pharm Pract. 2023 Jul; 29(5):1278-1282. Nemovi K, Jamali A, Matinpour K, Dasanu CA. PMID: 36785936.
      View in: PubMed   Mentions:
    31. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic mucosal melanoma. J Oncol Pharm Pract. 2023 Jul; 29(5):1259-1263. Goff CB, Plaxe SC, White W, Dasanu CA. PMID: 36734125.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Changing therapeutic landscape in advanced Kaposi sarcoma: Current state and future directions. J Oncol Pharm Pract. 2023 Jun; 29(4):917-926. Goff CB, Dasanu CA. PMID: 36718515.
      View in: PubMed   Mentions:
    33. Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States. EJHaem. 2023 Feb; 4(1):301-304. Castillo JJ, Kingsley EC, Narang M, Yimer HA, Dasanu CA, Melear JM, Coleman M, Farber CM, Shulman J, Mantovani EH, Zhang X, Cohen A, Huang J. PMID: 36819162; PMCID: PMC9928654.
      View in: PubMed   Mentions:
    34. Cycle-dependent eosinophilia due to adjuvant nivolumab for malignant melanoma. J Oncol Pharm Pract. 2023 Jul; 29(5):1255-1258. Habibi S, Soliman A, Dasanu CA. PMID: 36597613.
      View in: PubMed   Mentions:
    35. Acral Melanoma in an Elderly Patient with Congenital Ichthyosis Vulgaris. Acta Dermatovenerol Croat. 2022 11; 30(3):185-187. Neagu N, Cotoi OS, Sincu MC, Tincu AC, Dasanu CA, Ambros M. PMID: 36812279.
      View in: PubMed   Mentions:
    36. Selecting appropriate therapy for hairy cell leukemia: current state and future prospects based on molecularly defined characterization. Expert Opin Pharmacother. 2022 08; 23(11):1239-1241. Dasanu CA, Alvarez-Argote J, Goff CB. PMID: 35703589.
      View in: PubMed   Mentions:
    37. A fatal disseminated cryptococcal infection in a patient treated with zanubrutinib for Waldenström's macroglobulinemia. J Oncol Pharm Pract. 2022 Dec; 28(8):1917-1921. Patel D, Sidana M, Mdluli X, Patel V, Stapleton A, Dasanu CA. PMID: 35306909.
      View in: PubMed   Mentions:
    38. Cecal volvulus associated with carfilzomib use for al amyloidosis. J Oncol Pharm Pract. 2022 Jul; 28(5):1230-1233. Tuler S, Kaur J, Dasanu CA. PMID: 35089100.
      View in: PubMed   Mentions:
    39. Development of Monoclonal B-cell Lymphocytosis Shortly After Treatment with Nivolumab and Subsequent Progression to Chronic Lymphocytic Leukemia. J Oncol Pharm Pract. 2022 Jul; 28(5):1218-1221. Jamali A, Nemovi K, Kaur J, Dasanu CA. PMID: 35060786.
      View in: PubMed   Mentions:
    40. Necrotizing leg gangrene from invasive cutaneous Kaposi sarcoma, reversed by pegylated liposomal doxorubicin. J Oncol Pharm Pract. 2022 Jun; 28(4):1003-1008. Goff CB, Stapleton A, Aboulafia DM, Dasanu CA. PMID: 35037777.
      View in: PubMed   Mentions:
    41. Diabetic ketoacidosis as a hallmark of autoimmune diabetes occurring after two cycles of cemiplimab. J Oncol Pharm Pract. 2022 Apr; 28(3):722-724. Jouneghani NS, Phillip J, Dasanu CA. PMID: 34791931.
      View in: PubMed   Mentions:
    42. Kappa light chain restriction correlates with peripheral neuropathy in patients with non-IgM monoclonal gammopathy of undetermined significance. Eur J Haematol. 2022 Jan; 108(1):86-87. Dasanu CA, Kaur J, Farrell S, Plaxe SC. PMID: 34624145.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Sustained erythrocytosis due to the use of Lenvatinib. J Oncol Pharm Pract. 2022 Mar; 28(2):475-478. Kaur J, Tuler S, Dasanu CA. PMID: 34665694.
      View in: PubMed   Mentions:
    44. Evolving therapeutic strategies for advanced hepatocellular carcinoma. Expert Opin Pharmacother. 2021 Dec; 22(18):2495-2506. Qureshi A, Michel M, Lerner J, Dasanu CA. PMID: 34252328.
      View in: PubMed   Mentions:
    45. Acute gout flare of bilateral first metatarsophalangeal joints due to ibrutinib use in chronic lymphocytic leukemia. J Oncol Pharm Pract. 2022 Mar; 28(2):442-444. Kaur J, Tuler S, Dasanu CA. PMID: 34225525.
      View in: PubMed   Mentions:
    46. Advanced uterine papillary serous cancer: Could there be a role for newer targeted therapeutic approaches or immune checkpoint inhibitors? J Oncol Pharm Pract. 2021 Jul; 27(5):1181-1185. Dasanu CA, Lerner J, Ocampo MM, Iskandar AS, Kaur J, Tuler S, Codreanu I, Farrell S, Plaxe SC. PMID: 33983075.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy. J Oncol Pharm Pract. 2021 Oct; 27(7):1775-1778. Kaur J, Tuler S, Dasanu CA. PMID: 33446051.
      View in: PubMed   Mentions:
    48. Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin's lymphoma. J Oncol Pharm Pract. 2021 Sep; 27(6):1534-1538. Dang T, Macwan S, Dasanu CA. PMID: 33292071.
      View in: PubMed   Mentions:
    49. Cures with B-Raf inhibitors as single agents in metastatic B-Raf mutated melanoma: Curb your enthusiasm? J Oncol Pharm Pract. 2021 Jan; 27(1):205-206. Dasanu CA. PMID: 33241730.
      View in: PubMed   Mentions:
    50. Multidirectional pattern of hair growth with carflizomib use for multiple myeloma. J Oncol Pharm Pract. 2021 Jul; 27(5):1291-1295. Tuler S, Kaur J, Delaware S, Dasanu CA. PMID: 33050803.
      View in: PubMed   Mentions:
    51. Bluish-gray fingernail discoloration due to the use of nivolumab. J Oncol Pharm Pract. 2021 Mar; 27(2):457-459. Ocampo MM, Lerner J, Dasanu CA. PMID: 32517636.
      View in: PubMed   Mentions:
    52. Advanced papillary thyroid carcinoma responding to nivolumab. J Oncol Pharm Pract. 2021 Mar; 27(2):453-456. Michel Ocampo M, Lerner J, Tosonian S, Dasanu CA. PMID: 32507101.
      View in: PubMed   Mentions:
    53. 5-azacitidine reversing "spent" phase polycythemia vera back to proliferative phase and need for phlebotomy. J Oncol Pharm Pract. 2020 Jul; 26(5):1285-1288. Lerner J, Michel M, Dasanu CA. PMID: 32054413.
      View in: PubMed   Mentions:
    54. Severe terminal ileitis induced by single-agent nivolumab administered every four weeks. J Oncol Pharm Pract. 2020 Sep; 26(6):1516-1519. Dasanu CA, Plaxe SC, Gupta V, Popescu IM, Grover M, Alvarez-Argote J. PMID: 32028838.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    55. Relapsed refractory metastatic squamous cell cancer of anal canal in a patient with retroviral infection responding to cetuximab. J Oncol Pharm Pract. 2020 Jun; 26(4):1025-1028. Lerner J, Michel M, Dasanu CA. PMID: 31684821.
      View in: PubMed   Mentions:
    56. Angioedema late in the course of adjuvant nivolumab therapy for melanoma. J Oncol Pharm Pract. 2020 Jun; 26(4):1019-1021. Ratra A, Dasanu CA. PMID: 31635547.
      View in: PubMed   Mentions:
    57. Management and clinical outcomes in uterine malignant mixed Müllerian tumor: Lessons from a single-institution series. J Oncol Pharm Pract. 2020 Apr; 26(3):688-691. Dasanu CA, Iskandar AS, Hwang A, Kerr WT, Farrell S, Grover M, Ocampo MM, Lerner J, Plaxe SC. PMID: 31474213.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Durvalumab in cancer medicine: a comprehensive review. Expert Opin Biol Ther. 2019 09; 19(9):927-935. Alvarez-Argote J, Dasanu CA. PMID: 31272242.
      View in: PubMed   Mentions:
    59. Impact of therapeutic modalities on disease-specific survival in older adults with glioblastoma: A single-institution retrospective cohort study. J Oncol Pharm Pract. 2019 Dec; 25(8):1999-2003. Iskandar AS, Kerr WT, Hwang A, Farrell S, Plaxe SC, Dasanu CA. PMID: 31238807.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    60. Clinico-epidemiologic characteristics and patterns of care in Kaposi's sarcoma: Data from a single-institution series. J Oncol Pharm Pract. 2019 Oct; 25(7):1719-1721. Hwang A, Iskandar AS, Kerr WT, Farrell S, Plaxe SC, Dasanu CA. PMID: 30940048.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. Late-onset Stevens-Johnson syndrome due to nivolumab use for hepatocellular carcinoma. J Oncol Pharm Pract. 2019 Dec; 25(8):2052-2055. Dasanu CA. PMID: 30782092.
      View in: PubMed   Mentions:
    62. Merkel cell carcinoma: long-term follow-up of a single institution series and clinical outcomes by immunological status. Dermatol Online J. 2019 02 15; 25(2). Dasanu CA, Del Rosario M, Codreanu I, Lu Y, Farrell S, Hyams DM, Plaxe SC. PMID: 30865403.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    63. Severe left atrial enlargement due to carfilzomib use in multiple myeloma. J Oncol Pharm Pract. 2019 Dec; 25(8):2045-2048. Dasanu CA, Plaxe SC, Popescu IM, Gupta V, Sontz E, Codreanu I. PMID: 30636528.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Successful re-introduction of alectinib after inducing interstitial lung disease in a patient with lung cancer. J Oncol Pharm Pract. 2019 Sep; 25(6):1531-1533. Hwang A, Iskandar A, Dasanu CA. PMID: 30572795.
      View in: PubMed   Mentions:
    65. Bevacizumab in refractory higher-grade and atypical meningioma: the current state of affairs. Expert Opin Biol Ther. 2019 02; 19(2):99-104. Dasanu CA, Alvarez-Argote J, Limonadi FM, Codreanu I. PMID: 30556741.
      View in: PubMed   Mentions:
    66. Severe warm-antibody autoimmune hemolytic anemia due to multicentric Castleman disease: Responding to rituximab. J Oncol Pharm Pract. 2019 Dec; 25(8):2016-2018. Iskandar A, Hwang A, Dasanu CA. PMID: 30486744.
      View in: PubMed   Mentions:
    67. Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents? J Oncol Pharm Pract. 2019 Apr; 25(3):638-647. Dasanu CA, Samara Y, Codreanu I, Limonadi FM, Hamid O, Alvarez-Argote J. PMID: 30253729.
      View in: PubMed   Mentions:
    68. Polymyalgia rheumatica due to pembrolizumab therapy. J Oncol Pharm Pract. 2019 Jul; 25(5):1282-1284. Iskandar A, Hwang A, Dasanu CA. PMID: 30249155.
      View in: PubMed   Mentions:
    69. Stevens-Johnson syndrome manifesting late in the course of pembrolizumab therapy. J Oncol Pharm Pract. 2019 Sep; 25(6):1520-1522. Hwang A, Iskandar A, Dasanu CA. PMID: 30086678.
      View in: PubMed   Mentions:
    70. EGFR inhibitor-induced cut-like skin lesions of the fingers. BMJ Case Rep. 2018 Aug 01; 2018. Iskandar AS, Hwang A, Dasanu CA. PMID: 30068575; PMCID: PMC6078257.
      View in: PubMed   Mentions:
    71. Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors? J Oncol Pharm Pract. 2019 Jan; 25(1):214-216. Dasanu CA, Del Rosario M, Codreanu I, Hyams DM, Plaxe SC. PMID: 29933728.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    72. Severe arthritic syndrome due to ibrutinib use for chronic lymphocytic leukemia. J Oncol Pharm Pract. 2019 Jun; 25(4):1003-1005. Dasanu CA. PMID: 29720040.
      View in: PubMed   Mentions:
    73. Erythematous skin lesions with necrotic centers on lower extremities due to the use of ruxolitinib for primary myelofibrosis. J Oncol Pharm Pract. 2019 Jun; 25(4):990-992. Dasanu CA. PMID: 29651917.
      View in: PubMed   Mentions:
    74. Cystic acne due to imatinib therapy for chronic myelocytic leukemia. J Oncol Pharm Pract. 2019 Jun; 25(4):972-974. Hwang A, Iskandar A, Del Rosario M, Dasanu CA. PMID: 29498323.
      View in: PubMed   Mentions:
    75. Acute autoimmune myocarditis and hepatitis due to ipilimumab monotherapy for malignant melanoma. J Oncol Pharm Pract. 2019 Jun; 25(4):966-968. Samara Y, Yu CL, Dasanu CA. PMID: 29444608.
      View in: PubMed   Mentions:
    76. Durable Complete Response of Primary CNS Lymphoma in an 80-Year-Old Patient with Retroviral Infection. Conn Med. 2017 Apr; 81(4):223-226. Del Rosario M, Tsai H, Dasanu CA. PMID: 29714407.
      View in: PubMed   Mentions:
    77. Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer. J Oncol Pharm Pract. 2018 04; 24(3):229-231. Dasanu CA, Alvarez-Argote J, Lippman SM, Plaxe SC. PMID: 28436313.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    78. Persistent foot ulcer due to ruxolitinib therapy for primary myelofibrosis. J Oncol Pharm Pract. 2018 Apr; 24(3):226-228. Del Rosario M, Tsai H, Dasanu CA. PMID: 28436280.
      View in: PubMed   Mentions:
    79. Paraneoplastic Erythema Nodosum as a Prelude to Hodgkin Lymphoma. Conn Med. 2017 Mar; 81(3):157-160. Samara Y, Thomas J, Dasanu CA. PMID: 29772158.
      View in: PubMed   Mentions:
    80. Adenocarcinoma of the appendix occurring in a patient treated with paclitaxel for locally advanced esophageal cancer. J Oncol Pharm Pract. 2018 Mar; 24(2):150-152. Dasanu CA, Hyams DM, Senatore FJ. PMID: 28436298.
      View in: PubMed   Mentions:
    81. ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival. Curr Med Res Opin. 2018 05; 34(5):757-763. Alvarez Argote J, Dasanu CA. PMID: 28027687.
      View in: PubMed   Mentions:
    82. Primary squamous cell carcinoma of the thyroid with complete response to radical radiotherapy and concurrent cisplatin-based chemotherapy. BMJ Case Rep. 2017 Jan 18; 2017. Del Rosario M, Dasanu C, Tsai H, Johnson R. PMID: 28100571; PMCID: PMC5256516.
      View in: PubMed   Mentions:
    83. Strategy to reduce bortezomib-induced paralytic ileus in patients with myeloma and impaired renal function. BMJ Case Rep. 2016 Nov 29; 2016. Keating M, Dasanu CA. PMID: 27899388; PMCID: PMC5174818.
      View in: PubMed   Mentions:
    84. Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer. J Oncol Pharm Pract. 2017 Dec; 23(8):638-640. Dasanu CA, Lippman SM, Plaxe SC. PMID: 27824586.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    85. Multicentric Neuroendocrine Carcinoma of the Breast Presenting with Multiple Osteolytic Bone Metastases. Conn Med. 2016 10; 80(9):525-528. Del Rosario M, Tsai H, Dasanu CA. PMID: 29772135.
      View in: PubMed   Mentions:
    86. Prolonged Survival in Colon Cancer with Malignant Pericardial Effusion and Pulmonary Lymphangitic Carcinomatosis: A Case for Monoclonal Antibodies? Conn Med. 2016 Sep; 80(8):483-485. Del Rosario M, Tsai H, Dasanu CA. PMID: 29782785.
      View in: PubMed   Mentions:
    87. Erlotinib-Induced Transverse Fissure-Like Skin Lesions of Fingers. Conn Med. 2016 Sep; 80(7):405-407. Sadeghi M, Loftus R, Dasanu CA. PMID: 29782127.
      View in: PubMed   Mentions:
    88. A Curious Case of Actinomyces Naeslundii Bacteremia in a Patient with Metastatic Pancreatic Cancer. Conn Med. 2016 Sep; 80(7):417-418. De Keyser R, Ram A, Dasanu CA. PMID: 29782130.
      View in: PubMed   Mentions:
    89. Sustained clinico-radiologic response to anti-cytotoxic T lymphocyte antigen 4 antibody therapy in metastatic myxoid liposarcoma. J Oncol Pharm Pract. 2017 Oct; 23(7):549-551. Dasanu CA. PMID: 27511215.
      View in: PubMed   Mentions:
    90. Severe phototoxic reaction secondary to subcutaneous 5-azacitidine. J Oncol Pharm Pract. 2017 Sep; 23(6):473-475. Keating M, Dasanu CA. PMID: 27450683.
      View in: PubMed   Mentions:
    91. Late-onset pericardial tamponade, bilateral pleural effusions and recurrent immune monoarthritis induced by ipilimumab use for metastatic melanoma. J Oncol Pharm Pract. 2017 Apr; 23(3):231-234. Dasanu CA, Jen T, Skulski R. PMID: 26946531.
      View in: PubMed   Mentions:
    92. Accelerated Premalignant Polyposis and Second Colon Cancers: Incriminating Immunosuppression, Radiotherapy, and Systemic Chemotherapy Agents. J Gastrointest Cancer. 2016 Jun; 47(2):152-6. Senatore FJ, Murali S, Dasanu CA. PMID: 26957095.
      View in: PubMed   Mentions:
    93. Rapidly Fatal Dissemination of Merkel Cell Carcinoma in a Patient Treated with Alemtuzumab for Chronic Lymphocytic Leukemia. Conn Med. 2016 Jun-Jul; 80(6):353-8. Yu KK, Dasanu CA. PMID: 27509643.
      View in: PubMed   Mentions:
    94. Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. BBA Clin. 2016 Dec; 6:12-8. Shimanovsky A, Alvarez Argote J, Murali S, Dasanu CA. PMID: 27331023; PMCID: PMC4900299.
      View in: PubMed   Mentions:
    95. Fixed Drug Eruption Late in the Course of Capecitabine Therapy. Conn Med. 2016 Apr; 80(4):223-5. Del Rosario M, Tsai H, Dasanu CA. PMID: 27265926.
      View in: PubMed   Mentions:
    96. Late-onset robust curly hair growth in a patient with BRAF-mutated metastatic melanoma responding to dabrafenib. J Oncol Pharm Pract. 2017 Jun; 23(4):309-312. Keating M, Dasanu CA. PMID: 26946529.
      View in: PubMed   Mentions:
    97. Retinal Detachment and Symptomatic Hypercalcemia in a Patient with Sarcoidosis: Unusual Presentation of a Granulomatous Disease. Conn Med. 2016 Jan; 80(1):11-4. Khurana A, Cherian S, Majumder S, Nakrani R, Kowlgi GN, Dasanu CA. PMID: 26882785.
      View in: PubMed   Mentions:
    98. Reply To the Editor. J Oncol Pharm Pract. 2016 Jun; 22(3):575-6. Dasanu CA, Alexandrescu DT. PMID: 26471736.
      View in: PubMed   Mentions:
    99. Autoimmune disorders in patients with T-cell lymphoma: a comprehensive review. Curr Med Res Opin. 2015; 31(10):1861-70. Van den Bergh M, Alvarez-Argote J, Panwala AH, Dasanu CA. PMID: 26211818.
      View in: PubMed   Mentions:
    100. Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma. Conn Med. 2015 Aug; 79(7):401-4. Narra RK, Alvarez Argote J, Mesologites T, Dasanu CA. PMID: 26411176.
      View in: PubMed   Mentions:
    101. Prevalence and Pattern of Autoimmune Conditions in Patients with Marginal Zone Lymphoma: A Single Institution Experience. Conn Med. 2015 Apr; 79(4):197-200. Dasanu CA, Bockorny B, Grabska J, Codreanu I. PMID: 26259295.
      View in: PubMed   Mentions:
    102. Synchronous gastric and ampullary adenocarcinomas in a hairy cell leukemia patient treated with pentostatin eight years prior. J Oncol Pharm Pract. 2016 Jun; 22(3):543-7. Senatore FJ, Dasanu CA. PMID: 25712625.
      View in: PubMed   Mentions:
    103. Desmoid tumor mimicking GIST recurrence. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:125-8. Nandy N, Garvin W, Mesologites TL, Silver JS, Dasanu CA. PMID: 24573547.
      View in: PubMed   Mentions:
    104. HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence? Ann Hematol. 2015 Jan; 94(1):1-12. Bockorny B, Dasanu CA. PMID: 25416152; PMCID: PMC7079888.
      View in: PubMed   Mentions:
    105. Autoimmune disorders in patients with hairy cell leukemia: are they more common than previously thought? Curr Med Res Opin. 2015 Jan; 31(1):17-23. Dasanu CA, Van den Bergh M, Pepito D, Alvarez Argote J. PMID: 25265129.
      View in: PubMed   Mentions:
    106. Hepatitis associated aplastic anemia: case report and discussion. Conn Med. 2014 Sep; 78(8):493-5. Khurana A, Dasanu CA. PMID: 25314890.
      View in: PubMed   Mentions:
    107. Association between HBsAg positivity and pancreatic cancer: a meta-analysis. J Gastrointest Cancer. 2014 Sep; 45(3):347-52. Majumder S, Bockorny B, Baker WL, Dasanu CA. PMID: 24788082.
      View in: PubMed   Mentions:
    108. Inflammatory and immune-related conditions associated with Waldenström macroglobulinemia: a single center experience. Leuk Lymphoma. 2015 Apr; 56(4):1179-80. Atienza J, Bockorny B, Dadla A, Codreanu I, Dasanu CA. PMID: 25030038.
      View in: PubMed   Mentions:
    109. Operated bronchial carcinoids: clinical outcomes and long-term follow-up of a single institution series of 30 patients. Conn Med. 2014 Aug; 78(7):409-15. Jethava A, Codreanu I, Thayer J, Bandyopadhyay T, Ali S, Dasanu CA. PMID: 25195306.
      View in: PubMed   Mentions:
    110. Posterior reversible encephalopathy syndrome due to targeted agents: vemurafinib among suspects! J Oncol Pharm Pract. 2015 Dec; 21(6):443-50. Khurana A, Dasanu CA. PMID: 25013187.
      View in: PubMed   Mentions:
    111. Retroperitoneal fibrosis due to B-cell non-Hodgkin lymphoma: Responding to rituximab! J Oncol Pharm Pract. 2016 Feb; 22(1):179-85. Alvarez Argote J, Bauer FA, Posteraro AF, Dasanu CA. PMID: 25013186.
      View in: PubMed   Mentions:
    112. Pyoderma gangrenosum due to lenalidomide use for multiple myeloma. J Oncol Pharm Pract. 2015 Dec; 21(6):471-3. Dasanu CA, Bockorny B, Alexandrescu DT. PMID: 24986794.
      View in: PubMed   Mentions:
    113. Autoimmune manifestations in patients with Waldenström macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2014 Dec; 14(6):456-9. Bockorny B, Atienza JA, Dasanu CA. PMID: 25022601.
      View in: PubMed   Mentions:
    114. Adenocarcinoma of the ampulla of Vater: what treatment options are available? J Oncol Pharm Pract. 2015 Oct; 21(5):364-9. Senatore FJ, Ynson ML, Dasanu CA. PMID: 24906539.
      View in: PubMed   Mentions:
    115. Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy. J Transl Med. 2014 May 13; 12:127. Wagner SC, Markosian B, Ajili N, Dolan BR, Kim AJ, Alexandrescu DT, Dasanu CA, Minev B, Koropatnick J, Marincola FM, Riordan NH. PMID: 24884532; PMCID: PMC4028098.
      View in: PubMed   Mentions:
    116. Recurrent pseudocellulitis due to gemcitabine: underrecognized and underreported? J Oncol Pharm Pract. 2015 Oct; 21(5):377-9. Dasanu CA, Bockorny B. PMID: 24769519.
      View in: PubMed   Mentions:
    117. An unusual presentation of Kikuchi-Fujimoto disease. Conn Med. 2014 Apr; 78(4):225-8. Van den Bergh M, Bauer FA, Posteraro AF, Thumma S, Dasanu CA. PMID: 24830120.
      View in: PubMed   Mentions:
    118. CD5 negative mantle cell lymphoma: a different clinical entity? Conn Med. 2014 Apr; 78(4):211-4. Alvarez-Argote J, Bauer FA, Dasanu CA. PMID: 24830117.
      View in: PubMed   Mentions:
    119. What are the latest pharmacotherapy options for small bowel adenocarcinoma? Expert Opin Pharmacother. 2014 Apr; 15(6):745-8. Ynson ML, Senatore F, Dasanu CA. PMID: 24588646.
      View in: PubMed   Mentions:
    120. Respiratory failure due to lung involvement with adult T-cell leukemia/lymphoma: case report and review of literature. Conn Med. 2014 Mar; 78(3):139-42. Mutneja R, Shah M, Vyas D, Vyas A, Dasanu CA. PMID: 24772829.
      View in: PubMed   Mentions:
    121. Details of left ventricular radial wall motion supporting the ventricular theory of the third heart sound obtained by cardiac MR. Br J Radiol. 2014 May; 87(1037):20130780. Codreanu I, Robson MD, Rider OJ, Pegg TJ, Dasanu CA, Jung BA, Rotaru N, Clarke K, Holloway CJ. PMID: 24641347; PMCID: PMC4075536.
      View in: PubMed   Mentions:
    122. Updates on immunotherapy in non-small cell lung cancer. Expert Opin Biol Ther. 2014 Apr; 14(4):411-8. Shimanovsky A, Dasanu CA. PMID: 24512518.
      View in: PubMed   Mentions:
    123. Western variant of brain intravascular lymphoma displaying three distinct evolutive radiologic stages. Conn Med. 2014 Feb; 78(2):73-6. Dasanu CA, Codreanu I, Mesologites T, Ali S, Sullivan P, Jethava A. PMID: 24741854.
      View in: PubMed   Mentions:
    124. Second primary pancreatic adenocarcinoma three years after successfully treated index esophageal cancer. JOP. 2014 Jan 10; 15(1):46-8. Nandy N, Dasanu CA. PMID: 24413784.
      View in: PubMed   Mentions:
    125. Skin necrosis: a rare complication of protein S deficiency. Conn Med. 2014 Jan; 78(1):29-32. Jethava A, Mesologites T, Ali S, Dasanu CA. PMID: 24600778.
      View in: PubMed   Mentions:
    126. Effects of ventricular insertion sites on rotational motion of left ventricular segments studied by cardiac MR. Br J Radiol. 2013 Nov; 86(1031):20130326. Codreanu I, Robson MD, Rider OJ, Pegg TJ, Dasanu CA, Jung BA, Clarke K, Holloway CJ. PMID: 24133098; PMCID: PMC3830433.
      View in: PubMed   Mentions:
    127. Hematology consult: high-sensitivity warfarin genotype. Conn Med. 2013 Nov-Dec; 77(10):581-5. Schwer C, Lamana S, Dasanu CA. PMID: 24367840.
      View in: PubMed   Mentions:
    128. A curious case of oxaliplatin-induced neurotoxicity: recurrent, self-limiting dysarthria. J Oncol Pharm Pract. 2014 Oct; 20(5):393-6. Joseph R, Dasanu CA. PMID: 24103898.
      View in: PubMed   Mentions:
    129. Aleukemic leukemia presenting with paranoid psychosis. Conn Med. 2013 Oct; 77(9):537-9. Dasanu CA, Davis LK, Bauer F. PMID: 24266131.
      View in: PubMed   Mentions:
    130. Prevalence of autoimmune hematologic and non-hematologic conditions in large granular lymphocytic leukemia: exploratory analysis of a series of consecutive patients. Leuk Lymphoma. 2014 Jun; 55(6):1399-401. Bockorny B, Codreanu I, Dasanu CA. PMID: 23927392.
      View in: PubMed   Mentions:
    131. Mediastinal choriocarcinoma presenting with syncope. Conn Med. 2013 Sep; 77(8):473-5. Dasanu CA, Shimanovsky A, Jain K, Codreanu I. PMID: 24156175.
      View in: PubMed   Mentions:
    132. Immune alterations in malignant melanoma and current immunotherapy concepts. Expert Opin Biol Ther. 2013 Oct; 13(10):1413-27. Shimanovsky A, Jethava A, Dasanu CA. PMID: 23930800.
      View in: PubMed   Mentions:
    133. Gastrointestinal stromal tumor of small intestine and synchronous bilateral papillary renal cell carcinoma. Conn Med. 2013 Aug; 77(7):405-7. Dasanu CA, Jethava A, Ali S, Codreanu I. PMID: 24195178.
      View in: PubMed   Mentions:
    134. Hepatoid variant of pancreatic cancer: insights from a case and literature review. JOP. 2013 Jul 10; 14(4):442-5. Majumder S, Dasanu CA. PMID: 23846944.
      View in: PubMed   Mentions:
    135. Collision tumors: pancreatic adenocarcinoma and mantle cell lymphoma. JOP. 2013 Jul 10; 14(4):458-62. Dasanu CA, Shimanovsky A, Rotundo EK, Posteraro AF, Cooper DL, Atienza JA. PMID: 23846948.
      View in: PubMed   Mentions:
    136. Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review. Curr Med Res Opin. 2013 Sep; 29(9):1055-65. Nandy N, Dasanu CA. PMID: 23777310.
      View in: PubMed   Mentions:
    137. Malignant melanoma in pigmented skin: does the current interventional model fit a different clinical, histologic, and molecular entity? Dermatol Surg. 2013 Sep; 39(9):1291-303. Alexandrescu DT, Maslin B, Kauffman CL, Ichim TE, Dasanu CA. PMID: 23795952.
      View in: PubMed   Mentions:
    138. Immune alterations and immunotherapy prospects in head and neck cancer. Expert Opin Biol Ther. 2013 Sep; 13(9):1241-56. Varilla V, Atienza J, Dasanu CA. PMID: 23789839.
      View in: PubMed   Mentions:
    139. Management of advanced and/or metastatic carcinoid tumors: historical perspectives and emerging therapies. Expert Opin Pharmacother. 2013 Aug; 14(12):1649-58. Nandy N, Dasanu CA. PMID: 23746075.
      View in: PubMed   Mentions:
    140. Subcutaneous panniculitis-like T-cell lymphoma in a patient with history of B-cell lymphoma treated successfully with chemotherapy 15 years prior. J Oncol Pharm Pract. 2014 Jun; 20(3):233-5. Dasanu CA, Gopal S, Davis LK, Atienza JA. PMID: 23740379.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    141. Smoking-induced monoclonal B-lymphocytosis in two female smokers: what are the odds? Conn Med. 2013 Jun-Jul; 77(6):353-5. Dasanu CA. PMID: 23923254.
      View in: PubMed   Mentions:
    142. Vitamin B12 deficiency in patients undergoing bariatric surgery: preventive strategies and key recommendations. Surg Obes Relat Dis. 2013 Nov-Dec; 9(6):1013-9. Majumder S, Soriano J, Louie Cruz A, Dasanu CA. PMID: 24091055.
      View in: PubMed   Mentions:
    143. Methotrexate therapy leading to a rapid progression of a previously indolent prostate cancer: is immunosuppression to blame? J Oncol Pharm Pract. 2014 Apr; 20(2):149-53. Joseph R, Bockorny B, Dasanu CA. PMID: 23676505.
      View in: PubMed   Mentions:
    144. Normal values of regional and global myocardial wall motion in young and elderly individuals using navigator gated tissue phase mapping. Age (Dordr). 2014 Feb; 36(1):231-41. Codreanu I, Pegg TJ, Selvanayagam JB, Robson MD, Rider OJ, Dasanu CA, Jung BA, Taggart DP, Golding SJ, Clarke K, Holloway CJ. PMID: 23604860; PMCID: PMC3889897.
      View in: PubMed   Mentions:
    145. Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches. Expert Opin Biol Ther. 2013 Jun; 13(6):911-25. Bockorny B, Dasanu CA. PMID: 23586712.
      View in: PubMed   Mentions:
    146. Sustained paranoid psychosis in a patient with mast cell leukemia and decreased serotonin level. J Postgrad Med. 2013 Apr-Jun; 59(2):161-2. Dasanu CA, Davis LK, Bauer F. PMID: 23793328.
      View in: PubMed   Mentions:
    147. A case of polycythemia rubra vera transforming into chronic phase JAK2 V617F mutation-negative Philadelphia chromosome-positive chronic myelogenous leukemia. Leuk Lymphoma. 2013 Jul; 54(7):1567-8. Shimanovsky A, Bauer F, Silver J, Lamana S, Dasanu CA. PMID: 23369042.
      View in: PubMed   Mentions:
    148. Primary respiratory failure due to inclusion body myositis: think outside the box. Conn Med. 2013 Mar; 77(3):155-8. Jethava A, Ali S, Dasanu CA. PMID: 23589953.
      View in: PubMed   Mentions:
    149. Newer developments in the immunotherapy of malignant melanoma. J Oncol Pharm Pract. 2014 Feb; 20(1):3-10. Maslin B, Alexandrescu DT, Ichim TE, Dasanu CA. PMID: 23435643.
      View in: PubMed   Mentions:
    150. Pralatrexate : evaluation of clinical efficacy and toxicity in T-cell lymphoma. Expert Opin Pharmacother. 2013 Mar; 14(4):515-23. Shimanovsky A, Dasanu CA. PMID: 23409799.
      View in: PubMed   Mentions:
    151. An unusual presentation of a carcinoid tumor of the common bile duct. JOP. 2013 Jan 10; 14(1):85-7. Jethava A, Muralidharan V, Mesologites T, Stoica-Mustafa E, Dasanu CA. PMID: 23306342.
      View in: PubMed   Mentions:
    152. Muehrcke's lines (Leukonychia striata) due to transretinoic acid therapy for acute promyelocytic leukemia. J Oncol Pharm Pract. 2013 Dec; 19(4):377-9. Dasanu CA, Ichim TE, Alexandrescu DT. PMID: 23292969.
      View in: PubMed   Mentions:
    153. Adult biphasic pulmonary blastoma. Conn Med. 2013 Jan; 77(1):19-22. Jethava A, Dasanu CA. PMID: 23427368.
      View in: PubMed   Mentions:
    154. Neuroblastoma with a solitary intraventricular brain metastasis visualized on I-123 MIBG scan. J Neuroimaging. 2014 Mar-Apr; 24(2):202-4. Codreanu I, Dasanu CA, Zhuang H. PMID: 23279239.
      View in: PubMed   Mentions:
    155. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Curr Med Res Opin. 2012 Dec; 28(12):1899-909. Atienza JA, Dasanu CA. PMID: 23121148.
      View in: PubMed   Mentions:
    156. Exogenous endothelial cells as accelerators of hematopoietic reconstitution. J Transl Med. 2012 Nov 21; 10:231. Mizer JC, Ichim TE, Alexandrescu DT, Dasanu CA, Ramos F, Turner A, Woods EJ, Bogin V, Murphy MP, Koos D, Patel AN. PMID: 23171397; PMCID: PMC3543295.
      View in: PubMed   Mentions:
    157. Acute Wernicke encephalopathy and sensorineural hearing loss complicating bariatric surgery. Conn Med. 2012 Nov-Dec; 76(10):603-5. Jethava A, Dasanu CA. PMID: 23243762.
      View in: PubMed   Mentions:
    158. Peripheral blood immunophenotypic analysis as a diagnostic tool for large granular lymphocyte leukemia. Leuk Lymphoma. 2013 Feb; 54(2):435-7. Bockorny B, Conlon M, Dasanu CA. PMID: 22938095.
      View in: PubMed   Mentions:
    159. Anaphylactic reactions with intravenous vitamin K: lessons from the bedside. Conn Med. 2012 Oct; 76(9):549-50. Jethava A, Mathew J, Dasanu CA. PMID: 23155674.
      View in: PubMed   Mentions:
    160. Autoimmune manifestations in large granular lymphocyte leukemia. Clin Lymphoma Myeloma Leuk. 2012 Dec; 12(6):400-5. Bockorny B, Dasanu CA. PMID: 22999943.
      View in: PubMed   Mentions:
    161. Diffuse Signet-Ring Cell Gastric Adenocarcinoma "Linitis Plastica" and Pernicious Anemia: a Rare Association. J Gastrointest Cancer. 2012 Sep; 43 Suppl 1:S283-5. Majumder S, Habibi H, Gazi G, Dasanu CA. PMID: 22760711.
      View in: PubMed   Mentions:
    162. Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib. Hematol Oncol. 2013 Sep; 31(3):164-6. Dasanu CA, Bauer F, Codreanu I, Padmanabhan P, Rampurwala M. PMID: 22899491.
      View in: PubMed   Mentions:
    163. Length of adjuvant imatinib therapy in GIST: weighing benefits, side effects and costs. J Oncol Pharm Pract. 2012 Sep; 18(3):379-80. Dasanu CA. PMID: 22801957.
      View in: PubMed   Mentions:
    164. Bevacizumab in lung cancer: lackluster performance and unjustified expense? J Oncol Pharm Pract. 2012 Sep; 18(3):381-2. Dasanu CA. PMID: 22777997.
      View in: PubMed   Mentions:
    165. Multiple myeloma and its therapies: to what extent do they contribute to the increased incidence of second malignant neoplasms? Curr Med Res Opin. 2012 Jul; 28(7):1129-40. Dasanu CA, Mewawalla P, Grabska J. PMID: 22533678.
      View in: PubMed   Mentions:
    166. Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates. J Gastrointest Cancer. 2012 Jun; 43(2):137-47. Rustagi T, Dasanu CA. PMID: 21597894.
      View in: PubMed   Mentions:
    167. Syndrome of inappropriate antidiuretic hormone secretion due to marginal zone lymphoma: responding to rituximab. Clin Lymphoma Myeloma Leuk. 2012 Jun; 12(3):220-2. Bockorny B, Dasanu CA. PMID: 22578816.
      View in: PubMed   Mentions:
    168. Immune alterations and emerging immunotherapeutic approaches in lung cancer. Expert Opin Biol Ther. 2012 Jul; 12(7):923-37. Dasanu CA, Sethi N, Ahmed N. PMID: 22559147.
      View in: PubMed   Mentions:
    169. Low-dose computed tomography: could it be applied for secondary prevention in patients undergoing resection for lung cancer? J Thorac Oncol. 2012 May; 7(5):943-4. Dasanu CA, Codreanu I. PMID: 22722800.
      View in: PubMed   Mentions:
    170. Cardiovascular toxicity associated with small molecule tyrosine kinase inhibitors currently in clinical use. Expert Opin Drug Saf. 2012 May; 11(3):445-57. Dasanu CA, Padmanabhan P, Clark BA, Do C. PMID: 22469002.
      View in: PubMed   Mentions:
    171. Hair repigmentation associated with the use of lenalidomide: graying may not be an irreversible process! J Oncol Pharm Pract. 2013 Jun; 19(2):165-9. Dasanu CA, Mitsis D, Alexandrescu DT. PMID: 22440400.
      View in: PubMed   Mentions:
    172. Catastrophic arteriovenous thromboembolism as initial manifestation of pancreatic cancer. JOP. 2012 Mar 10; 13(2):231-4. Majumder S, Thom T, Dasanu CA. PMID: 22406609.
      View in: PubMed   Mentions:
    173. Monostotic Paget's disease involving the calcaneus encountered incidentally on bone scintigraphy. Foot (Edinb). 2012 Sep; 22(3):135-7. Codreanu I, Lim E, Dasanu CA. PMID: 22386214.
      View in: PubMed   Mentions:
    174. Rapidly progressive colonic dysplasia/neoplasia in a series of treated lung cancer patients: Is paclitaxel involved? J Oncol Pharm Pract. 2013 Mar; 19(1):82-5. Kaur A, Dasanu CA. PMID: 22323421.
      View in: PubMed   Mentions:
    175. Functional 'composite' pheochromocytoma-ganglioneuroma presenting as a pancreatic mass. Pancreatology. 2012 May-Jun; 12(3):211-4. Majumder S, Grabska J, Trikudanathan G, Kowalczyk P, Stoica-Mustafa E, Dasanu CA. PMID: 22687375.
      View in: PubMed   Mentions:
    176. Persistent polyclonal B-cell lymphocytosis in chronic smokers: more than meets the eye. Conn Med. 2012 Feb; 76(2):69-72. Dasanu CA, Codreanu I. PMID: 22670354.
      View in: PubMed   Mentions:
    177. Emerging therapeutic options for advanced enteropancreatic neuroendocrine tumors. Expert Opin Pharmacother. 2012 Mar; 13(4):461-71. Dasanu CA, Majumder S, Gopal S, Stoica-Mustafa E, Trikudanathan G. PMID: 22292707.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    178. Fluorodeoxyglucose-induced allergic reaction: a case report. J Oncol Pharm Pract. 2013 Mar; 19(1):86-8. Codreanu I, Dasanu CA, Weinstein GS, Divgi C. PMID: 22267446.
      View in: PubMed   Mentions:
    179. Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature. Br J Haematol. 2012 Jan; 156(1):50-66. Bockorny B, Codreanu I, Dasanu CA. PMID: 22017478.
      View in: PubMed   Mentions:
    180. Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma. Expert Opin Pharmacother. 2011 Nov; 12(16):2493-503. Kaur A, Dasanu CA. PMID: 21967344.
      View in: PubMed   Mentions:
    181. IFN-conditioned dendritic cells for the therapy of melanoma: what is missing? J Immunother. 2011 Oct; 34(8):607-609. Alexandrescu DT, Ichim TE, Riordan NH, Marincola FM, Dasanu CA. PMID: 22025902; PMCID: PMC3184394.
      View in: PubMed   Mentions:
    182. Images in clinical medicine. Splenic calcification. N Engl J Med. 2011 Sep 15; 365(11):1042. Dasanu CA, Codreanu I. PMID: 21916642.
      View in: PubMed   Mentions:
    183. Synchronous tumors: adenosquamous carcinoma of pancreas and GIST of stomach. J Gastrointest Cancer. 2011 Sep; 42(3):186-9. Dasanu CA, Mesologites T, Trikudanathan G. PMID: 20623381.
      View in: PubMed   Mentions:
    184. Immune alterations in untreated and treated multiple myeloma. J Oncol Pharm Pract. 2012 Jun; 18(2):257-63. Dasanu CA. PMID: 21859744.
      View in: PubMed   Mentions:
    185. Refractory DKA as first presentation of acromegaly and a potential role for continuous venovenous hemofiltration in its successful management. Conn Med. 2011 Aug; 75(7):405-7. Mewawalla P, Jaiswal G, Moustakakis M, Sankaranarayanan N, Dasanu CA. PMID: 21905534.
      View in: PubMed   Mentions:
    186. Details of left ventricular remodeling and the mechanism of paradoxical ventricular septal motion after coronary artery bypass graft surgery. J Invasive Cardiol. 2011 Jul; 23(7):276-82. Codreanu I, Pegg TJ, Selvanayagam JB, Robson MD, Rider OJ, Dasanu CA, Jung BA, Taggart DP, Clarke K, Holloway CJ. PMID: 21725122.
      View in: PubMed   Mentions:
    187. High-grade solitary extramedullary plasmacytoma arising in skeletal muscle of a kidney transplant recipient. Leuk Res. 2011 Sep; 35(9):e181-3. Bidros M, Bauer F, Codreanu I, Dasanu CA. PMID: 21700337.
      View in: PubMed   Mentions:
    188. Autoimmune phenomena in untreated and treated marginal zone lymphoma. Expert Opin Pharmacother. 2011 Oct; 12(15):2369-79. Grabska J, Dasanu CA. PMID: 21679092.
      View in: PubMed   Mentions:
    189. Rapidly fatal acute ATLL emerging after methotrexate therapy for disseminated psoriasis. Clin Lymphoma Myeloma Leuk. 2012 Feb; 12(1):76-8. Dasanu CA, Bauer F, Ichim TE, Vyas D, Ek K, Alexandrescu DT. PMID: 21729685.
      View in: PubMed   Mentions:
    190. Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out. Vasc Health Risk Manag. 2011; 7:365-73. Codreanu I, Robson MD, Rider OJ, Pegg TJ, Jung BA, Dasanu CA, Clarke K, Holloway CJ. PMID: 21731888; PMCID: PMC3119594.
      View in: PubMed   Mentions:
    191. Emerging pharmacotherapeutic strategies for cholangiocarcinoma. Expert Opin Pharmacother. 2011 Aug; 12(12):1865-74. Dasanu CA, Majumder S, Trikudanathan G. PMID: 21585239.
      View in: PubMed   Mentions:
    192. Isolated thrombocytopenia: should we routinely screen for antiphospholipid antibodies? Conn Med. 2011 May; 75(5):281-4. Dasanu CA, Codreanu I. PMID: 21678840.
      View in: PubMed   Mentions:
    193. Newer developments in adult T-cell leukemia/lymphoma therapeutics. Expert Opin Pharmacother. 2011 Aug; 12(11):1709-17. Dasanu CA. PMID: 21486117.
      View in: PubMed   Mentions:
    194. Moderate cytopenias in asymptomatic individuals: is screening for autoimmune connective tissue diseases warranted? J Postgrad Med. 2011 Apr-Jun; 57(2):178-9. Dasanu CA, Do C. PMID: 21654151.
      View in: PubMed   Mentions:
    195. A curious case of a 'burned-out' hypereosinophilic syndrome. Leuk Res. 2011 Jul; 35(7):e141-2. Dasanu CA, Cohen S, Bauer F. PMID: 21429579.
      View in: PubMed   Mentions:
    196. Immune alterations in untreated and treated myelodysplastic syndrome. Expert Opin Drug Saf. 2011 May; 10(3):351-61. Mewawalla P, Dasanu CA. PMID: 21417834.
      View in: PubMed   Mentions:
    197. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med. 2011 Mar 04; 9:25. Ichim TE, Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ, Miranda-Massari JR, Alexandrescu DT, Dasanu CA, Bogin V, Ancans J, Stevens RB, Markosian B, Koropatnick J, Chen CS, Riordan NH. PMID: 21375761; PMCID: PMC3061919.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    198. Polycystic ovary syndrome: focus on platelets and prothrombotic risk. South Med J. 2011 Mar; 104(3):174-8. Dasanu CA, Clark BA, Ichim TE, Alexandrescu DT. PMID: 21297528.
      View in: PubMed   Mentions:
    199. Lemierre syndrome caused by group C streptococci and associated with red cell aplasia and immune thrombocytopenia. South Med J. 2011 Mar; 104(3):244-6. Mewawalla P, Bauer F, Dasanu CA. PMID: 21297542.
      View in: PubMed   Mentions:
    200. Polycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide. Leuk Res. 2011 May; 35(5):e41-3. Dasanu CA, Schwartz RA, Bauer F, Davis LK, Silver JS, Reale MA. PMID: 21288571.
      View in: PubMed   Mentions:
    201. Targeting macrophages in classical Hodgkin's lymphoma may seem rational, but is it safe? J Oncol Pharm Pract. 2012 Mar; 18(1):104-8. Dasanu CA. PMID: 21248172.
      View in: PubMed   Mentions:
    202. Newer developments in the therapeutics of the transitional cell carcinoma of renal pelvis. J Oncol Pharm Pract. 2012 Mar; 18(1):97-103. Dasanu CA, Ong-Bacay A, Codreanu I. PMID: 21248173.
      View in: PubMed   Mentions:
    203. On the missing link between inflammation and cancer. Dermatol Online J. 2011 Jan 15; 17(1):10. Alexandrescu DT, Riordan NH, Ichim TE, Kauffman CL, Kabigting F, Dutton CT, Dasanu CA. PMID: 21272501.
      View in: PubMed   Mentions:
    204. Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia. Dermatol Online J. 2011 Jan 15; 17(1):2. Alexandrescu DT, Kauffman CL, Ichim TE, Riordan NH, Kabigting F, Dasanu CA. PMID: 21272493.
      View in: PubMed   Mentions:
    205. Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP. 2011 Jan 05; 12(1):26-31. Trikudanathan G, Philip A, Dasanu CA, Baker WL. PMID: 21206097.
      View in: PubMed   Mentions:
    206. Thrombocytopenia in NAFLD: is thrombopoietin involved? South Med J. 2010 Dec; 103(12):1278-9. Dasanu CA, Lamana S, Trikudanathan G. PMID: 21037521.
      View in: PubMed   Mentions:
    207. Squamous cell lung cancer presenting with pulmonary lymphangitic carcinomatosis. J Ark Med Soc. 2010 Dec; 107(7):132-4. Homsi S, Milojkovic N, Mesologites T, Homsi Y, Dasanu CA. PMID: 21197869.
      View in: PubMed   Mentions:
    208. Generalized cerebral atrophy seen on MRI in a naturally exposed animal model for Creutzfeldt-Jakob disease. J Transl Med. 2010 Nov 26; 8:125. McKnight AL, Minkoff LA, Sutton DL, Thomsen BV, Habecker PL, Sweeney RW, Smith G, Dasanu CA, Ichim TE, Alexandrescu DT, Stutman JM. PMID: 21108848; PMCID: PMC3009697.
      View in: PubMed   Mentions:
    209. Congenital combined deficiency of coagulation factors VII and II in a young adult. Conn Med. 2010 Nov-Dec; 74(10):581-3. Dasanu CA, Natale FO, DeSilva HN. PMID: 21189713.
      View in: PubMed   Mentions:
    210. Alpha-thalassemia genetic testing: an important anemia diagnostic tool in patients of African heritage. Conn Med. 2010 Nov-Dec; 74(10):585-7. Dasanu CA. PMID: 21189714.
      View in: PubMed   Mentions:
    211. Refractory metastatic thyroid cancer: is Doxorubicin still a valid treatment option? South Med J. 2010 Nov; 103(11):1191-2. Dasanu CA. PMID: 20890262.
      View in: PubMed   Mentions:
    212. Thrombocytopenia, NAFLD, and metabolic syndrome: is there a link? South Med J. 2010 Oct; 103(10):1071. Dasanu CA, Lamana S, Trikudanathan G. PMID: 20818317.
      View in: PubMed   Mentions:
    213. Paraneoplastic psoriasiform dermatitis preceding the diagnosis of chronic myelogenous leukemia. Leuk Res. 2010 Dec; 34(12):e331-3. Dasanu CA, Bauer F, Alexandrescu DT. PMID: 20846721.
      View in: PubMed   Mentions:
    214. Adenosquamous carcinoma of the pancreas: a distinct clinicopathologic entity. South Med J. 2010 Sep; 103(9):903-10. Trikudanathan G, Dasanu CA. PMID: 20697320.
      View in: PubMed   Mentions:
    215. Hyperviscosity syndrome in a patient with kappa light chain myeloma with cryoglobulin properties and alpha thalassemia. Leuk Res. 2010 Dec; 34(12):e315-6. Dasanu CA, Mewawalla P, Geller AB, Silver JS. PMID: 20708798.
      View in: PubMed   Mentions:
    216. Small cell lung cancer with paraneoplastic lipase production. South Med J. 2010 Aug; 103(8):819-22. Dasanu CA, Clark BA, Lahiri B, Ichim TE, Alexandrescu DT. PMID: 20622741.
      View in: PubMed   Mentions:
    217. Tumor fever, paraneoplastic leukocytosis and necrotic liver metastases: a triad worth remembering. Conn Med. 2010 Aug; 74(7):389-91. Dasanu CA, Trikudanathan G, Bandyopadhyay T, Lahiri B, Homsi S, Clark BA. PMID: 20806616.
      View in: PubMed   Mentions:
    218. Cholangiocarcinoma and paraneoplastic hypercalcemia: a lethal combination revisited. South Med J. 2010 Jul; 103(7):716-8. Trikudanathan G, Dasanu CA. PMID: 20531035.
      View in: PubMed   Mentions:
    219. Immunotherapy for melanoma: current status and perspectives. J Immunother. 2010 Jul-Aug; 33(6):570-90. Alexandrescu DT, Ichim TE, Riordan NH, Marincola FM, Di Nardo A, Kabigting FD, Dasanu CA. PMID: 20551839; PMCID: PMC3517185.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    220. Evolving pharmacotherapeutic strategies for small bowel adenocarcinoma. Expert Opin Pharmacother. 2010 Jul; 11(10):1695-704. Trikudanathan G, Dasanu CA. PMID: 20446863.
      View in: PubMed   Mentions:
    221. Bortezomib: friend or foe of hemolytic anemia? J Oncol Pharm Pract. 2011 Sep; 17(3):233-5. Dasanu CA. PMID: 20562167.
      View in: PubMed   Mentions:
    222. Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention? Panminerva Med. 2010 Jun; 52(2 Suppl 1):75-80. Ichim TE, Zhong Z, Mikirova NA, Jackson JA, Hunninghake R, Mansilla E, Marín G, Núñez L, Patel AN, Angle N, Murphy MP, Dasanu CA, Alexandrescu DT, Bogin V, Riordan NH. PMID: 20657539.
      View in: PubMed   Mentions:
    223. Diffuse large B-cell lymphoma with lung involvement in a psoriatic arthritis patient treated with methotrexate. Dermatol Online J. 2010 May 15; 16(5):1. Homsi S, Alexandrescu DT, Milojkovic N, Abouzgheib W, Bachour K, Homsi Y, Dasanu CA. PMID: 20492818.
      View in: PubMed   Mentions:
    224. Chronic lymphocytic leukemia presenting with cholecystitis-like symptoms and gallbladder wall invasion. South Med J. 2010 May; 103(5):482-4. Dasanu CA, Mesologites T, Homsi S, Ichim TE, Alexandrescu DT. PMID: 20375943.
      View in: PubMed   Mentions:
    225. Complete heart block secondary to bortezomib use in multiple myeloma. J Oncol Pharm Pract. 2011 Sep; 17(3):282-4. Dasanu CA. PMID: 20406745.
      View in: PubMed   Mentions:
    226. Tumor vaccines in 2010: need for integration. Cell Immunol. 2010; 263(2):138-47. Koos D, Josephs SF, Alexandrescu DT, Chan RC, Ramos F, Bogin V, Gammill V, Dasanu CA, De Necochea-Campion R, Riordan NH, Carrier E. PMID: 20434139.
      View in: PubMed   Mentions:
    227. Lasers, stem cells, and COPD. J Transl Med. 2010 Feb 16; 8:16. Lin F, Josephs SF, Alexandrescu DT, Ramos F, Bogin V, Gammill V, Dasanu CA, De Necochea-Campion R, Patel AN, Carrier E, Koos DR. PMID: 20158898; PMCID: PMC2830167.
      View in: PubMed   Mentions:
    228. Mantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide. Leuk Res. 2010 Jul; 34(7):e178-80. Dasanu CA, Reale MA, Bauer F. PMID: 20079532.
      View in: PubMed   Mentions:
    229. Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol. 2010; 260(2):75-82. Ichim TE, Alexandrescu DT, Solano F, Lara F, Campion Rde N, Paris E, Woods EJ, Murphy MP, Dasanu CA, Patel AN, Marleau AM, Leal A, Riordan NH. PMID: 19917503.
      View in: PubMed   Mentions:
    230. Risk of additional cancers in untreated and treated hairy cell leukemia patients. Expert Opin Pharmacother. 2010 Jan; 11(1):41-50. Dasanu CA, Alexandrescu DT. PMID: 20001428.
      View in: PubMed   Mentions:
    231. Inherent and iatrogenic immune defects in hairy cell leukemia: revisited. Expert Opin Drug Saf. 2010 Jan; 9(1):55-64. Dasanu CA, Ichim TE, Alexandrescu DT. PMID: 20001754.
      View in: PubMed   Mentions:
    232. Large granular lymphocytic (LGL) leukemia in an adult with Down syndrome (47,XX,+21). Leuk Res. 2010 May; 34(5):e125-7. Dasanu CA, Bauer F. PMID: 20022373.
      View in: PubMed   Mentions:
    233. Acute scurvy during treatment with interleukin-2. Clin Exp Dermatol. 2009 Oct; 34(7):811-4. Alexandrescu DT, Dasanu CA, Kauffman CL. PMID: 19094121.
      View in: PubMed   Mentions:
    234. Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe? J Oncol Pharm Pract. 2010 Dec; 16(4):266-8. Dasanu CA, Alexandrescu DT. PMID: 19965947.
      View in: PubMed   Mentions:
    235. A case of prekallikrein deficiency resulting in severe recurrent mucosal hemorrhage. Am J Med Sci. 2009 Nov; 338(5):429-30. Dasanu CA, Alexandrescu DT. PMID: 19773642.
      View in: PubMed   Mentions:
    236. H. pylori-associated gastric cancer in a husband-wife pair: a veritable family affair. South Med J. 2009 Nov; 102(11):1158-60. Dasanu CA, Rathmann J, Alexandrescu DT. PMID: 19864985.
      View in: PubMed   Mentions:
    237. Carboplatin-gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration. J Oncol Pharm Pract. 2010 Mar; 16(1):63-6. Dasanu CA, Herzog TJ, Alexandrescu DT. PMID: 19525302.
      View in: PubMed   Mentions:
    238. Acute gout during treatment with paclitaxel for metastatic melanoma. Rheumatology (Oxford). 2009 Jul; 48(7):862-3. Alexandrescu DT, Ichim TE, Kabigting F, Dasanu CA. PMID: 19458161.
      View in: PubMed   Mentions:
    239. Does bortezomib induce de facto varicella zoster virus reactivation in patients with multiple myeloma? J Clin Oncol. 2009 May 01; 27(13):2293-4; author reply 2294-6. Dasanu CA, Alexandrescu DT. PMID: 19307496.
      View in: PubMed   Mentions:
    240. Persistent hair growth during treatment with the EGFR inhibitor erlotinib. Dermatol Online J. 2009 Mar 15; 15(3):4. Alexandrescu DT, Kauffman CL, Dasanu CA. PMID: 19379648.
      View in: PubMed   Mentions:
    241. The cutaneous epidermal growth factor network: Can it be translated clinically to stimulate hair growth? Dermatol Online J. 2009 Mar 15; 15(3):1. Alexandrescu DT, Kauffman CL, Dasanu CA. PMID: 19379645.
      View in: PubMed   Mentions:
    242. Malignant melanoma in African-Americans. Dermatol Online J. 2009 Feb 15; 15(2):3. Kabigting FD, Nelson FP, Kauffman CL, Popoveniuc G, Dasanu CA, Alexandrescu DT. PMID: 19336020.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    243. mTOR-blocking agents in advanced renal cancer: an emerging therapeutic option. Expert Opin Investig Drugs. 2009 Feb; 18(2):175-87. Dasanu CA, Clark BA, Alexandrescu DT. PMID: 19236264.
      View in: PubMed   Mentions:
    244. Bilateral Leser-Trélat sign mirroring lung adenocarcinoma with early metastases to the contralateral lung. South Med J. 2009 Feb; 102(2):216-8. Dasanu CA, Alexandrescu DT. PMID: 19209445.
      View in: PubMed   Mentions:
    245. Clear cell adenocarcinoma of the ovary associated with in utero diethylstilbestrol exposure: case report and clinical overview. Medscape J Med. 2009; 11(1):6. Dasanu CA, Herzog TJ. PMID: 19295927; PMCID: PMC2654676.
      View in: PubMed   Mentions:
    246. A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma. Eur J Haematol. 2009 Mar; 82(3):231-4. Dasanu CA, Alexandrescu DT. PMID: 19018868.
      View in: PubMed   Mentions:
    247. Gemcitabine: vascular toxicity and prothrombotic potential. Expert Opin Drug Saf. 2008 Nov; 7(6):703-16. Dasanu CA. PMID: 18983217.
      View in: PubMed   Mentions:
    248. Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer. South Med J. 2008 Nov; 101(11):1161-2. Dasanu CA, Alexandrescu DT. PMID: 19088531.
      View in: PubMed   Mentions:
    249. Acute retinal pigment epithelial detachment secondary to pamidronate administration. J Oncol Pharm Pract. 2009 Jun; 15(2):119-21. Dasanu CA, Alexandrescu DT. PMID: 18818218.
      View in: PubMed   Mentions:
    250. Development of squamous cell carcinomas in Darier disease: a new model for skin carcinogenesis? Br J Dermatol. 2008 Dec; 159(6):1378-80. Alexandrescu DT, Dasanu CA, Farzanmehr H, Kauffman CL. PMID: 18808417.
      View in: PubMed   Mentions:
    251. Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib. J Clin Oncol. 2008 Aug 20; 26(24):4047-8. Alexandrescu DT, McClure R, Farzanmehr H, Dasanu CA. PMID: 18711201.
      View in: PubMed   Mentions:
    252. Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST. Dermatol Online J. 2008 Jul 15; 14(7):7. Alexandrescu DT, Dasanu CA, Farzanmehr H, Kauffman L. PMID: 18718191.
      View in: PubMed   Mentions:
    253. Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies. Thyroid. 2008 Jul; 18(7):809-12. Alexandrescu DT, Popoveniuc G, Farzanmehr H, Dasanu CA, Dawson N, Wartofsky L. PMID: 18631016.
      View in: PubMed   Mentions:
    254. Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice. Expert Opin Pharmacother. 2008 Jun; 9(9):1481-94. Dasanu CA. PMID: 18518779.
      View in: PubMed   Mentions:
    255. Bilateral perinephric diffuse large B-cell lymphoma and synchronous renal oncocytoma. South Med J. 2008 Feb; 101(2):196-8. Dasanu CA, Alexandrescu DT. PMID: 18364624.
      View in: PubMed   Mentions:
    256. Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia. MedGenMed. 2007 Nov 15; 9(4):35. Dasanu CA, Alexandrescu DT. PMID: 18311385; PMCID: PMC2234297.
      View in: PubMed   Mentions:
    257. Yellow skin discoloration associated with sorafenib use for treatment of metastatic renal cell carcinoma. South Med J. 2007 Mar; 100(3):328-30. Dasanu CA, Alexandrescu DT, Dutcher J. PMID: 17396743.
      View in: PubMed   Mentions:
    258. A complex pattern of melanonychia and onycholysis after treatment with pemetrexed for lung cancer. Skinmed. 2007 Mar-Apr; 6(2):95-6. Dasanu CA, Wiernik PH, Vaillant J, Alexandrescu DT. PMID: 17366681.
      View in: PubMed   Mentions:
    259. Kidney cancer therapy: new perspectives and avenues. Expert Opin Pharmacother. 2006 Dec; 7(18):2481-93. Alexandrescu DT, Dasanu CA. PMID: 17150003.
      View in: PubMed   Mentions:
    260. Distinct patterns of chromonychia, Beau's lines, and melanoderma seen with vincristine, adriamycin, dexamethasone therapy for multiple myeloma. Dermatol Online J. 2006 Oct 31; 12(6):10. Dasanu CA, Vaillant JG, Alexandrescu DT. PMID: 17083890.
      View in: PubMed   Mentions:
    261. Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitors. Clin Exp Dermatol. 2007 Jan; 32(1):71-4. Alexandrescu DT, Vaillant JG, Dasanu CA. PMID: 17034418.
      View in: PubMed   Mentions:
    262. Action of some proteic and carbohydrate components of Symphytum officinale upon normal and neoplastic cells. Roum Arch Microbiol Immunol. 1993 Apr-Jun; 52(2):73-80. Olinescu A, Manda G, Neagu M, Hristescu S, Dasanu C. PMID: 8186457.
      View in: PubMed   Mentions:
    Constantin's Networks
    Concepts (796)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-21-g9d46e6c4 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California